整合策略鉴定与定量心可舒片质量标志物
本研究采用斑马鱼幼鱼心率恢复率评价心可舒片抗心律失常作用,结合HPLC指纹图谱与OSC-PLSR分析、网络药理学、UHPLC-Q-Exactive HRMS及斑马鱼模型验证,鉴定丹参素、丹酚酸A、丹酚酸B、大豆苷元和葛根素为质量标志物,并对16批样品进行定量。
要点
- 斑马鱼幼鱼心率恢复率可用于评价心可舒片抗心律失常作用。
- 丹参素、丹酚酸A、丹酚酸B、大豆苷元和葛根素被鉴定为质量标志物。
- 所建方法对16批心可舒片样品进行了定量分析。
核心结论
- 丹参素、丹酚酸A、丹酚酸B、大豆苷元和葛根素被鉴定为心可舒片的质量标志物。
- 所建立的整合策略可用于其他中成药质量标志物的鉴定与定量。
研究设计与样本
- 采用斑马鱼幼鱼心率恢复率评价心可舒片抗心律失常作用。
- 获取16批心可舒片样品的HPLC指纹图谱。
- 采用OSC-PLSR分析建立谱效关系鉴定抗心律失常成分。
- 利用网络药理学映射心血管疾病相关靶点鉴定抗心血管疾病成分。
- 采用UHPLC-Q-Exactive HRMS鉴定体内吸收和暴露的化合物。
主要发现
- 通过谱效关系、网络药理学和血浆药物化学研究,结合质量标志物五原则及斑马鱼心律失常模型验证,鉴定出5个质量标志物。
- 对16批心可舒片样品进行了定量分析。
关键数值与推荐
- 以斑马鱼幼鱼心率恢复率为传统药理效应指标。
- 采用OSC-PLSR分析建立HPLC指纹图谱与心率恢复率的谱效关系。
- 基于质量标志物五原则和斑马鱼心律失常模型验证质量标志物。
临床怎么用
- 所鉴定的质量标志物可用于心可舒片的质量控制。
- 整合策略可推广用于其他中成药质量标志物的鉴定与定量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Xinkeshu tablets (XKST), a traditional Chinese patent medicine (CPM), have served in the clinical treatment of cardiovascular diseases (CVDs) for decades. However, its pharmacodyamic material basis was still unclear, and the holistic quality control has not been well established due to the lack of systematic research on the quality markers. In this experiment, the heart rate recovery rate of a zebrafish larva was used to evaluate the traditional pharmacological effect of XKST i.e., antiarrhythmic effect. The HPLC fingerprints of 16 batches of XKST samples were obtained, and antiarrhythmic components of XKST were identified by establishing the spectrum-effect relationship between HPLC fingerprints and heart rate recovery rate of zebrafish larva with orthogonal signal correction and partial least squares regression (OSC-PLSR) analysis. The anticardiovascular disease components of XKST were identified by mapping the targets related to CVDs in network pharmacology. The compounds of XKST absorbed and exposed in vivo were identified by ultra-high performance liquid chromatography Q-Exactive high-resolution mass spectrometry (UHPLC-Q-Exactive HRMS). Based on the earlier studies, combined with five principles for identifying quality markers and verified by a zebrafish arrhythmia model, danshensu, salvianolic acid A, salvianolic acid B, daidzein, and puerarin were identified as quality markers of XKST. In total, 16 batches of XKST samples were further quantified with the method established in this study. Our study laid the foundation for the quality control of XKST. The integrated strategy used in the study of XKST could be applied for the identification and quantification of quality markers of other CPMs as well.
引用
- Wei Y, Nie L, Gao L, et al. An Integrated Strategy to Identify and Quantify the Quality Markers of Xinkeshu Tablets Based on Spectrum-Effect Relationship, Network Pharmacology, Plasma Pharmacochemistry, and Pharmacodynamics of Zebrafish. Front Pharmacol. 2022. PMID: 35677447. doi:10.3389/fphar.2022.899038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。